Perrigo to Buy Elan for $8.6B to Get Irish Tax Base

July 29 (Bloomberg) -- Perrigo, a U.S. maker of over-the-counter medicines, agreed to buy Irish drug company Elan for $8.6 billion, gaining a low-tax base for international expansion. Olivia Sterns reports on Bloomberg Television's "Taking Stock." (Source: Bloomberg)

Yuan Goes Global: Can It Become Top Currency?
46:31 - Brandywine Global co-director Chen Zhao discusses the Chinese yuan joining the International Monetary Fund with Bloomberg's Joe Weisenthal and Scarlet Fu on "What'd You Miss?" (Source: Bloomberg)
  • Is China's Economy on Its Way Up?
  • Deep Dive: Saudi Libor Rates, Oil Prices
  • Why Oil Prices May Be Near a Bottom